- Home
- NABL vs IMTX Comparison
NABL vs IMTX Comparison
Compare NABL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NABL | IMTX |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NABL | IMTX |
|---|---|---|
| Price | $7.18 | $9.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $9.31 | ★ $19.25 |
| AVG Volume (30 Days) | ★ 814.4K | 468.5K |
| Earning Date | 11-06-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $497,665,000.00 | $99,445,031.00 |
| Revenue This Year | $11.18 | N/A |
| Revenue Next Year | $8.73 | $19.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.65 | N/A |
| 52 Week Low | $6.07 | $3.30 |
| 52 Week High | $10.41 | $12.41 |
Technical Indicators
Market Signals| Indicator | NABL | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 41.60 |
| Support Level | $7.07 | $9.21 |
| Resistance Level | $7.48 | $10.19 |
| Average True Range (ATR) | 0.21 | 0.50 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 22.22 | 12.99 |
Price Performance
Historical ComparisonAbout NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.